The use of scintigraphic imaging during liposome drug development

B. A. Goins, William T Phillips

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Liposomes, spherical lipid bilayers enclosing an aqueous space, have become an important class of drug carriers. This review describes the usefulness of scintigraphic imaging during the development of liposome-based drugs. This imaging modality is particularly helpful for tracking the distribution of liposomes in the body, monitoring the therapeutic responses following administration of liposome-based drugs, and investigating the physiological responses associated with liposome administration. Scintigraphy also can be used to monitor the therapeutic responses of patients given approved liposomal drugs. Several examples describing the potential of this imaging modality during both the preclinical formulation and clinical trial stages of liposomal drug development are included. Techniques for radiolabeling liposomes as well as methods for producing scintigraphic images are also described.

Original languageEnglish (US)
Pages (from-to)397-406
Number of pages10
JournalJournal of Pharmacy Practice
Volume14
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Liposomes
Pharmaceutical Preparations
Drug Carriers
Lipid Bilayers
Radionuclide Imaging
Clinical Trials
Therapeutics

Keywords

  • Liposomes
  • Positron emission tomography
  • Radionuclide imaging
  • Scintigraphy
  • Technetium-99m

ASJC Scopus subject areas

  • Pharmacology

Cite this

The use of scintigraphic imaging during liposome drug development. / Goins, B. A.; Phillips, William T.

In: Journal of Pharmacy Practice, Vol. 14, No. 5, 2001, p. 397-406.

Research output: Contribution to journalArticle

Goins, B. A. ; Phillips, William T. / The use of scintigraphic imaging during liposome drug development. In: Journal of Pharmacy Practice. 2001 ; Vol. 14, No. 5. pp. 397-406.
@article{155bf4ac0b1c40f0bfe74884b135f4d1,
title = "The use of scintigraphic imaging during liposome drug development",
abstract = "Liposomes, spherical lipid bilayers enclosing an aqueous space, have become an important class of drug carriers. This review describes the usefulness of scintigraphic imaging during the development of liposome-based drugs. This imaging modality is particularly helpful for tracking the distribution of liposomes in the body, monitoring the therapeutic responses following administration of liposome-based drugs, and investigating the physiological responses associated with liposome administration. Scintigraphy also can be used to monitor the therapeutic responses of patients given approved liposomal drugs. Several examples describing the potential of this imaging modality during both the preclinical formulation and clinical trial stages of liposomal drug development are included. Techniques for radiolabeling liposomes as well as methods for producing scintigraphic images are also described.",
keywords = "Liposomes, Positron emission tomography, Radionuclide imaging, Scintigraphy, Technetium-99m",
author = "Goins, {B. A.} and Phillips, {William T}",
year = "2001",
doi = "10.1106/DA2M-FYJU-1XXQ-PPKK",
language = "English (US)",
volume = "14",
pages = "397--406",
journal = "Journal of Pharmacy Practice",
issn = "0897-1900",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - The use of scintigraphic imaging during liposome drug development

AU - Goins, B. A.

AU - Phillips, William T

PY - 2001

Y1 - 2001

N2 - Liposomes, spherical lipid bilayers enclosing an aqueous space, have become an important class of drug carriers. This review describes the usefulness of scintigraphic imaging during the development of liposome-based drugs. This imaging modality is particularly helpful for tracking the distribution of liposomes in the body, monitoring the therapeutic responses following administration of liposome-based drugs, and investigating the physiological responses associated with liposome administration. Scintigraphy also can be used to monitor the therapeutic responses of patients given approved liposomal drugs. Several examples describing the potential of this imaging modality during both the preclinical formulation and clinical trial stages of liposomal drug development are included. Techniques for radiolabeling liposomes as well as methods for producing scintigraphic images are also described.

AB - Liposomes, spherical lipid bilayers enclosing an aqueous space, have become an important class of drug carriers. This review describes the usefulness of scintigraphic imaging during the development of liposome-based drugs. This imaging modality is particularly helpful for tracking the distribution of liposomes in the body, monitoring the therapeutic responses following administration of liposome-based drugs, and investigating the physiological responses associated with liposome administration. Scintigraphy also can be used to monitor the therapeutic responses of patients given approved liposomal drugs. Several examples describing the potential of this imaging modality during both the preclinical formulation and clinical trial stages of liposomal drug development are included. Techniques for radiolabeling liposomes as well as methods for producing scintigraphic images are also described.

KW - Liposomes

KW - Positron emission tomography

KW - Radionuclide imaging

KW - Scintigraphy

KW - Technetium-99m

UR - http://www.scopus.com/inward/record.url?scp=0035213078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035213078&partnerID=8YFLogxK

U2 - 10.1106/DA2M-FYJU-1XXQ-PPKK

DO - 10.1106/DA2M-FYJU-1XXQ-PPKK

M3 - Article

AN - SCOPUS:0035213078

VL - 14

SP - 397

EP - 406

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

SN - 0897-1900

IS - 5

ER -